Treating patients for hepatitis C could reduce the need for liver transplants
(European Association for the Study of the Liver) A new study presented today demonstrates that patients on the liver transplant list with hepatitis C virus (HCV) and severe liver damage were more likely to be taken off the list or have their need of a liver transplant reduced as a result of direct-acting antiviral therapy.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Antiviral Therapy | Hepatitis | Hepatitis C | Infectious Diseases | Liver | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology